2,189
+0.74%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Eiken Chemical Co
Its shares trade on Tokyo Stock Exchange under the ticker 4549.T. It has been listed since 29 January 1990. In the fiscal year to 31 March 2026, it reported revenue of ¥41.90bn and net income of ¥3.71bn. At that date it held total assets of ¥62.66bn and shareholders' equity of ¥44.03bn.
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. The company is headquartered in Taito-Ku, Tokyo-To. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 29 Jan 1990
- Employees
- 754
- Website
- eiken.co.jp ↗
Leadership
Pay as last reported
- Mr. Morifumi WadaChairman of the Board, since 2006
- Mr. Tsugunori NotomiExecutive President, Chief Executive Officer, Representative Executive Officer, Director, since 2009
- Mr. Hajime WatariSenior Managing Executive Officer, Senior Director of Business Administration, Director, since 2016
- Mr. Naomichi HaradaManaging Executive Officer, Senior Director of Sales
- Mr. Hidetoshi KandaManaging Executive Officer, Senior Director of Research Development
- Mr. Michitoshi DoiExecutive Officer, Senior Director of Production, Manager of Production Management Office, Manager of Reliability Assurance Office
- Mr. Hiroyasu FuruhashiExecutive Officer, Manager of Nogi Plant in Production Supervision Unit
- Mr. Yasuyoshi MoriExecutive Officer, Manager of Overseas Business Office in Sales Supervision Unit, Chairman of Subsidiary
- Mr. Shinya SadamotoExecutive Officer, Manager of Internal Audit Office
- Mr. Yuji SegawaExecutive Officer, Manager of Marketing Office in Sales Supervision Unit
- Mr. Tetsuya TakahashiExecutive Officer, Manager of Sales Promotion Office in Sales Supervision Unit
- Mr. Akira FujiyoshiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 74
- Environment
- 99
- Social
- 85
- Governance
- 37
- Direct emissions (scope 1)
- 1,945 t
- Energy emissions (scope 2)
- 2,669 t
- Value chain emissions (scope 3)
- 84,205 t
- Women in the workforce
- 29.2%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company employs 754 full-time employees.
- Headquartered in Taito-ku, Tokyo-To.
- Engages in manufacture and sale of clinical diagnostics products and equipment.
Weaknesses
- No specific weaknesses mentioned in the provided information.
- No financial data provided for analysis.
- No market share or competitive position details available.
Opportunities
- Expansion into processing, manufacture, purchase, and sale of test agents through subsidiaries.
- Growth potential in microbial testing reagents market.
- Potential for increased sales of immunoserologic testing reagents.
Threats
- No specific threats mentioned in the provided information.
- No competitive landscape details provided.
- No regulatory or market challenges described.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.